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Abstract Cyclic nucleotide second messengers are increasingly implicated in prokaryotic anti-
viral defence systems. Type III CRISPR systems synthesise cyclic oligoadenylate (cOA) upon
detecting foreign RNA, activating ancillary nucleases that can be toxic to cells, necessitating
mechanisms to remove cOA in systems that operate via immunity rather than abortive infection.
Previously, we demonstrated that the Sulfolobus solfataricus type III-D CRISPR complex generates
cyclic tetra-adenylate (cA4), activating the ribonuclease Csx1, and showed that subsequent RNA
cleavage and dissociation acts as an ‘off-switch’ for the cyclase activity. Subsequently, we identified
the cellular ring nuclease Crn1, which slowly degrades cA4 to reset the system (Rouillon et al.,
2018), and demonstrated that viruses can subvert type III CRISPR immunity by means of a potent
anti-CRISPR ring nuclease variant AcrIII-1. Here, we present a comprehensive analysis of the
dynamic interplay between these enzymes, governing cyclic nucleotide levels and infection
outcomes in virus-host conflict.
Introduction
CRISPR systems are widespread in archaea and bacteria, providing adaptive immunity against invad-
ing mobile genetic elements (MGE) (Sorek et al., 2013; Makarova et al., 2020). Type III CRISPR sys-
tems (Figure 1) are multi-functional effector proteins that have specialised in the detection of
foreign RNA (Tamulaitis et al., 2017; Zhu et al., 2018). The large subunit, Cas10, harbours two
enzyme active sites that are activated by target RNA binding: a DNA-cleaving HD nuclease domain
(Samai et al., 2015; Elmore et al., 2016; Estrella et al., 2016; Kazlauskiene et al., 2016) and a
cyclase domain for cyclic oligoadenylate (cOA) synthesis (Kazlauskiene et al., 2017;
Niewoehner et al., 2017; Rouillon et al., 2018). The third enzymatic activity of type III systems is
situated in the Cas7 subunit of the complex, which cleaves bound RNA targets and in turn regulates
Cas10 enzymatic activities (Tamulaitis et al., 2014; Rouillon et al., 2018; Johnson et al., 2019;
Nasef et al., 2019). The cyclase domain polymerises ATP into cOA species consisting of between
3 and 6 AMP subunits (denoted cA3, cA4 etc.), in varying proportions (Kazlauskiene et al., 2017;
Niewoehner et al., 2017; Rouillon et al., 2018; Gru¨schow et al., 2019; Nasef et al., 2019). cOA
second messengers activate CRISPR ancillary nucleases of the Csx1/Csm6, Can1 (CRISPR associated
nuclease 1) and NucC families, which drive the immune response against MGEs (Kazlauskiene et al.,
2017; Niewoehner et al., 2017; Rouillon et al., 2018; Gru¨schow et al., 2019; Lau et al., 2020;
McMahon et al., 2020). To date, cA4 appears to be the most widely used signalling molecule by
type III CRISPR systems (Gru¨schow et al., 2019). The ribonuclease activity of Csx1/Csm6 is crucial
for the clearance of MGEs (Hatoum-Aslan et al., 2014; Foster et al., 2019; Gru¨schow et al., 2019),
particularly when viral genes are transcribed late in infection, at low levels or mutated (Hatoum-
Aslan et al., 2014; Jiang et al., 2016; Rostøl and Marraffini, 2019).
Athukoralage et al. eLife 2020;9:e55852. DOI: https://doi.org/10.7554/eLife.55852 1 of 16
RESEARCH ADVANCE
In our previous study, we demonstrated that the type III-D system from Sulfolobus solfataricus
synthesises predominantly cA4, which activates the CRISPR ancillary ribonuclease Csx1. We exam-
ined the first regulatory step in cOA synthesis in detail and demonstrated that target RNA cleavage
and dissociation from the complex shut-off cOA synthesis (Rouillon et al., 2018). Since CRISPR ancil-
lary nucleases degrade nucleic acids non-specifically, cellular as well as viral targets are destroyed.
Collateral cleavage of self-transcripts by a Csm6 enzyme has previously been shown to result in cell
growth arrest (Rostøl and Marraffini, 2019). Therefore, in addition to regulating the synthesis of
cOA, cells need a mechanism to remove extant cOA if they are to return to normal growth. To solve
this problem, S. solfataricus encodes CRISPR-associated ring nuclease 1 (Crn1) family enzymes
(Athukoralage et al., 2018). Crn1 enzymes slowly degrade cA4 to yield di-adenylate products inca-
pable of activating Csx1. In other species Csm6 proteins have evolved catalytic CARF domains
Figure 1. Cartoon of type III CRISPR cyclic nucleotide signalling and defence in Sulfolobus solfataricus. The Cas10 subunit of the type III CRISPR
complex synthesises cyclic tetra-adenylate (cA4) when viral RNA transcripts are detected. Target RNA cleavage shuts-off cA4 synthesis. cA4 binds to the
CARF (CRISPR associated Rossmann Fold) domain of CRISPR ancillary nuclease Csx1 and allosterically activates its HEPN (Higher Eukaryotes and
Prokaryotes Nucleotide binding) domain, which degrades RNA non-specifically within the cell. Extant cA4 is degraded slowly by CRISPR ring nucleases
(Crn1 family) which likely facilitate cell recovery after clearing the virus. Viral anti-CRISPR ring nucleases (AcrIII-1 family) degrade cA4 rapidly to stop
activation of ancillary defence enzymes such as Csx1 and supress antiviral immunity.
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capable of degrading cA4, thereby acting as their own ‘off-switches’ to their RNase activity
(Athukoralage et al., 2019; Jia et al., 2019). Unsurprisingly, archaeal viruses and bacteriophage
have co-opted this regulatory strategy in order to subvert type III CRISPR defence. Many archaeal
viruses and bacteriophage encode a ring nuclease anti-CRISPR (AcrIII-1), unrelated to Crn1, which
neutralises the type III response by rapidly degrading cA4 to prevent ancillary nuclease activation
(Athukoralage et al., 2020).
It is clear that the cA4 antiviral second messenger is at the centre of a network of interactions that
are crucial for effective type III CRISPR defence against MGE. Here, we show that detection of even
a single molecule of invading RNA has the potential to generate a large signal amplification via syn-
thesis of cA4 that in turn activates the non-specific degradative ribonuclease Csx1. We explore how
a cellular ring nuclease can return the cell to a basal state and how viruses can subvert the system.
By quantifying and modelling the equilibria and reactions that take place in the arena of type III
CRISPR defence, we build a comprehensive model of this dynamic, life or death process.
Results
While the control of cOA synthesis by target RNA binding and cleavage is now understood reason-
ably well, the full implications of cOA generation in a virally-infected cell are not. This requires a
detailed knowledge of the levels of cOA produced, consequences for antiviral defence enzymes and
the effects of cOA degrading enzymes from cellular and viral sources. These were the aims of our
study.
Signal amplification on cA4 production
We first investigated the extent of signal amplification that occurs in a cell from detection of a single
viral RNA and generation of the cA4 second messenger. Using the S. solfataricus type III-D CRISPR
effector, we varied the concentration of target RNA and quantified the resultant cA4 production. As
previously observed (Rouillon et al., 2018), increasing the target RNA concentration resulted in
increased cA4 production (Figure 2). Quantification of the concentration of cA4 generated was
accomplished by using a-32P-ATP and quantification of products using a phosphorimager in compar-
ison to standards (Figure 2—figure supplement 1). We observed that approximately 1000 mole-
cules (980 ± 24) of cA4 were generated per molecule of RNA, over a range of 10–100 nM target
RNA (Figure 2). When a poorly-cleavable target RNA species containing phosphorothioates was
used as the substrate, the amount of cA4 generated increased approximately 3-fold (3100 ± 750,
Figure 2), confirming the important role of RNA cleavage for deactivation of the cyclase domain
(Rouillon et al., 2018; Nasef et al., 2019). Additionally, analysis of previously published data
enabled us to determine the catalytic rate constant (k) of cA4 synthesis by the S. solfataricus type III
effector as 0.04 ± 0.01 min 1 at 70˚C (Figure 2—figure supplement 2).
Given that S. solfataricus cells are cocci with a diameter of approximately 0.7 mm, the volume of
an average cell can be calculated as approximately 0.3 fL (by comparison, E. coli has a cell volume of
1 fL [Kubitschek and Friske, 1986]). Using Avogadro’s number, 1000 molecules equates to an intra-
cellular concentration of 6 mM cA4 in S. solfataricus. Thus, detection of one viral RNA in the cell could
result in the synthesis of 6 mM cA4, 10 RNAs – 60 mM, etc. The upper limits of cA4 generation could
be defined by the number of viral target RNAs present, the number of type III effectors carrying a
crRNA matching that target, or even conceivably the amount of ATP available for cA4 generation.
Kinetic parameters of the Csx1 ribonuclease
The cA4 second messenger binds to CARF family proteins to elicit an immune response. To under-
stand the concentration of cA4 required to activate an antiviral response, we determined the dissoci-
ation constant of the major ancillary ribonuclease Csx1 for the cA4 activator. Using radioactive cA4,
we titrated an increasing concentration of Csx1 protein and subjected the mixture to native gel elec-
trophoresis (Figure 3A,B). cA4 was bound by Csx1 with a dissociation constant (KD) of 130 ± 20 nM.
Thus, even one viral target RNA detected by the type III CRISPR system should generate enough
cA4 (6 mM) to fully activate the Csx1 ribonuclease for defence. We proceeded to estimate the bind-
ing affinity of a ribonuclease-deficient Csx1 variant for its RNA target, yielding an apparent dissocia-
tion constant of approximately 5 mM (Figure 3C). Finally, we measured the initial velocity of RNA
degradation at a variety of RNA concentrations under steady state conditions and determined the
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Figure 2. Approximately 1000 molecules cA4 are made per molecule of RNA target. (A) Upper panel shows phosphorimages of thin-layer
chromatography of cyclic tetra-adenylate (cA4) made by S. solfataricus (Sso) Csm complex (470 nM carrying the CRISPR RNA A26) across a range of
RNA target concentrations (0.1, 1, 10, 25,100 nM) complementary to the A26 CRISPR RNA at 70˚C. Lower panel shows cA4 synthesised with a cleavage
resistant (phosphorothioate) form of the RNA target. (B) Bar graph of the concentration of cA4 generated with increasing cleavable and cleavage-
resistant RNA target generated by quantifying the densiometric signals from A, with an a-32P-ATP standard curve (Figure 2—figure supplement 1).
Error bars indicate the standard deviation of the mean of three technical replicates, with individual data points shown as clear circles. No data are
shown for 1 nM cleavable RNA target as cA4 generated was below detection limits. (C) Bar chart quantifying the number of molecules of cA4 generated
per molecule of cleavable or cleavage resistant target RNA across a range of RNA target concentrations. On average SsoCsm synthesised 980 ± 24 and
3100 ± 750 molecules of cA4 per molecule of cleavable and cleavage resistant target RNA, respectively. (D) Cartoon depicting the cellular implications
of ~1000 molecules of cA4 generated per molecule of RNA target, which in S. solfataricus would equate to ~6 mM cA4 within the cell.
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Source data 1. Excel spreadsheet with raw data.
Figure supplement 1. Example of ATP standard curve used to determine the concentration of ATP converted to cyclic tetra-adenylate (cA4).
Figure supplement 2. Rate of cA4 synthesis by S. solfataricus type III-D effector complex.
Figure supplement 2—source data 1. Excel speadsheet with raw data.
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Figure 3. Csx1 binds cA4 with high affinity and RNA with relatively low affinity. (A) Phosphorimage of native gel electrophoresis visualising cA4 (20 nM)
binding by Csx1 (concentrations as indicated in the figure). The other bands visible are due to unreacted ATP and other linear nucleotide products. (B)
Plot of fraction of cA4 bound by Csx1. Error bars indicate the standard deviation of the mean of four technical replicates and the data were fitted to a
quadratic equation incorporating a term for non-specific binding. The inset plot is a magnification of cA4 binding between 0.01 and 5 mM Csx1 dimer
concentrations. (C) Phosphorimage of native gel electrophoresis visualising A1 substrate RNA binding by Csx1 H345N protein dimer in the absence (left
hand-side) or presence (right hand-side) of unlabelled cA4 (20 mM). The image shown is representative of three technical replicates. Control c – RNA
alone.
The online version of this article includes the following source data for figure 3:
Source data 1. Csx1 binding to cA4 and RNA.
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multiple-turnover kinetic constant (kcat) for cA4-activated RNA cleavage by Csx1 as 0.44 ± 0.03
min 1 at 70˚C (Figure 4).
Kinetic and equilibrium constants of the ring nucleases Crn1 and AcrIII-
1
We have previously established that Crn1 cleaved cA4 at a rate of 0.089 ± 0.003 min
 1 at 50˚C, while
AcrIII-1 cleaved cA4 at a rate of 5.4 ± 0.38 min
 1, about 60-fold faster (Athukoralage et al., 2020).
The difference in reaction rates probably reflects the different roles of the two enzymes, with Crn1
working in conjunction with the type III CRISPR defence and AcrIII-1 opposing it. To quantify the
interaction between ring nucleases and cA4, we titrated radioactively labelled cA4 with either Crn1
or AcrIII-1 and visualised cA4 binding by phosphorimaging following native gel electrophoresis. Crn1
bound cA4 with an apparent KD of ~50 nM, while the inactive H47A variant of AcrIII-1 bound cA4
with an apparent KD of ~25 nM (Figure 5). Thus, both ring nucleases bound cA4 three to four-fold
more tightly than Csx1.
Kinetic modelling of the antiviral signalling pathway and its regulation
by cA4 degrading enzymes
We entered the experimentally determined kinetic and equilibria parameters into the KinTek Global
Kinetic Explorer software package and generated a model to simulate RNA degradation by Csx1
and the effects of ring nucleases over time (Figure 6A). Enzyme concentrations were set initially at 1
mM, based on published studies of transcript levels (Ortmann et al., 2008; Wurtzel et al., 2010),
but were varied during modelling to assess the influence of enzyme concentration on RNA cleavage.
We standardised the reaction temperature at 70˚C, close to the growth temperature of S. solfatari-
cus. This necessitated an estimation of the rate constants of Crn1 and AcrIII-1, which were measured
at lower temperatures, based on a 2-fold increase in activity for each 10˚C rise in temperature, in line
Figure 4. Degradation of RNA by Csx1. Analysis of multiple-turnover, steady state kinetics of A1 RNA cleavage by Csx1 (125 nM dimer) at 70˚C. The
data were fitted to the Michaelis-Menten equation and error bars show the standard deviation of the mean of three technical replicates.
The online version of this article includes the following source data for figure 4:
Source data 1. Excel spreadsheet with data for kinetics of Csx1.
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with our previous studies of these enzymes (Athukoralage et al., 2018; Athukoralage et al., 2020).
To model the generation of cA4 by the Csm:target RNA complex, we set the concentration of that
complex at 6, 60 or 600 mM (equivalent to low, medium and high levels of infection), allowing the
generation of the equivalent concentration of cA4 with the measured rate constant of 0.04 min
 1
(Figure 6A). Henceforth, this will be referred to as 6, 60 or 600 mM cA4 for simplicity.
In the absence of any ring nuclease activity, 1 mM Csx1 was fully activated, degrading all 1000 mM
RNA provided in the simulation within 2400 min, regardless of the simulated level of infection (Fig-
ure 6—figure supplement 1). The lack of titration of Csx1 activity observed here is due to its high
affinity for cA4, resulting in full activation even at very low simulated infection levels. We observed a
rapid initial increase in the levels of cA4 due to synthesis by the activated Csm complex (Figure 6B).
In the simulations, 1 mM Crn1 degraded 60 mM cA4 within 120 min, but took over 1200 min to
degrade 600 mM cA4 (Figure 6B). These differences were reflected in the levels of Csx1-mediated
RNA degradation, which were much higher for 600 mM cA4 than for the lower concentrations
(Figure 6C). Thus, the kinetic modelling demonstrated that addition of a ring nuclease activity allows
the cell to respond differently to varied levels of infection, and therefore cA4 concentration, resulting
in a range of RNA degradation levels.
We next introduced the AcrIII-1 enzyme to the simulation, to model the effect of the Acr on the
host defence system. Strikingly, when AcrIII-1 was present at 1 mM, even 600 mM cA4 was degraded
rapidly (the bulk within 10 min). As a result, Csx1 activity and therefore RNA degradation were
strongly supressed (Figure 6D,E). The long tail of cA4 observed in these simulations represents cA4
bound to the Csx1 enzyme and thus unavailable for degradation by AcrIII-1, reflected in the persis-
tence of active Csx1-cA4 complex in the simulations over an extended period (Figure 6—figure sup-
plement 2). Notably, at the highest simulated infection level of 600 mM cA4, Csx1 persists in a 100%
Figure 5. Crn1 and AcrIII-1 bind cA4 with high affinity. Phosphorimages of native gel electrophoresis visualising radiolabelled cyclic oligoadenylate
(cOA) binding by (A) Crn1 (B) and catalytically inactive AcrIII-1 (SIRV1 gp29 H47A). Crn1 binds cA4 (10 nM) with an apparent dissociation constant (KD)
of ~50 nM, whereas AcrIII-1 binds cA4 with an apparent KD of ~25 nM. The images shown are representative of three technical replicates. Control c –
cOA alone. The other bands near the bottom of the gel are caused by unreacted ATP and other linear products.
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Figure 6. Modelling of S. solfataricus antiviral signalling. (A) Schematic showing kinetic and equilibrium parameters inserted into the KinTek Global
Kinetic Explorer software for modelling the type III CRISPR defence illustrated in Figure 1. Parameters have been determined in this study with the
following exceptions: Crn1 rate constant of 0.46 min 1 at 70˚C estimated from rate of 0.23 min 1 measured at 60˚C and AcrIII-1 rate constant of 21.6
min 1 at 70˚C estimated from rate of 5.4 min 1 measured at 50˚C (Athukoralage et al., 2020). The parameter ‘target-Csm-ATP’ was set at 6, 60 or 600
Figure 6 continued on next page
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activated form for over 1200 min in the absence of AcrIII-1, but is reduced to 50% activated within
150 min in its presence, with similar effects seen at lower cA4 concentrations (Figure 6—figure sup-
plement 2).
The concentration of AcrIII-1 within S. solfataricus cells during infection is not known. We there-
fore varied AcrIII-1 concentration in the model (with 60 mM cA4, 1 mM Csx1 and Crn1) and simulated
RNA cleavage (Figure 6F). AcrIII-1 concentrations as low as 100 nM reduced RNA cleavage by about
30%, and higher levels reduced RNA cleavage by Csx1 markedly (Figure 6F). This relationship held
in simulations with 600 mM cA4 (Figure 6F, Figure 6—figure supplement 3). During infection, a pos-
itive correlation between AcrIII-1 concentration and viral transcript levels would be required for con-
tinued escape from Csx1-mediated CRISPR defence – a reasonable assumption. Finally, we
simulated the effects of increasing Csx1 on RNA cleavage in our infection model. Increasing Csx1
concentration 10-fold led to a significantly more robust immune response (reflected in high levels of
RNA degradation) (Figure 6G) that could not be fully overcome by increasing the concentrations of
Crn1 or AcrIII-1 in proportion (compare for example 10,10,10 with 1,1,1 mM in Figure 6G). Hence,
increasing the expression levels of defence nucleases such as Csx1 in response to viral infection
could provide an effective means for cells to combat viruses armed with Acrs such as AcrIII-1, but
perhaps with the cost of increased toxicity.
Discussion
Signal amplification in type III CRISPR defence
In this study, we used biochemical data to build a kinetic model of the type III CRISPR antiviral sig-
nalling pathway within S. solfataricus cells and examined the capacity of CRISPR and anti-CRISPR
ring nucleases for its regulation. Quantification of cA4 generated by the SsoCsm complex in vitro
revealed that ~ 1000 molecules of cA4 are made per RNA target, amounting to a concentration of 6
mM in the cell if replicated in vivo. This large degree of signal amplification would ensure that detec-
tion of 1 RNA target could generate sufficient amounts of cA4 to fully activate the ribonuclease
effector protein Csx1, which has a dissociation constant for cA4 of 0.13 mM. Given the large signal
amplification observed here, it seems likely that some means of cOA degradation, either via self-lim-
iting ribonucleases (Athukoralage et al., 2019; Jia et al., 2019) or dedicated ring nucleases
(Athukoralage et al., 2018), will be essential for type III CRISPR systems to provide immunity rather
than elicit abortive infection. Indeed, growth arrest has been observed for cOA activated Csm6 dur-
ing bacteriophage infection (Rostøl and Marraffini, 2019). This life or death decision in response to
genotoxic stress has also been observed in S. islandicus, which becomes dormant upon viral infec-
tion and subsequently dies if virus remains in culture (Bautista et al., 2015). In recent years, diverse
CRISPR systems have been implicated in abortive infection or cell dormancy. The Type I-F CRISPR
system of Pectobacterium atrosepticum was found to provide population protection by aborting
infection when infected by virulent phage (Watson et al., 2019). Likewise, the in-trans collateral
Figure 6 continued
mM in simulations. Underscores connecting two variables indicate their relationship in a complex. cA4, cyclic tetra-adenylate; Crn1, CRISPR ring nuclease
1; AcrIII-1, viral ring nuclease anti-CRISPR SIRV1 gp29; Csx1, CRISPR ancillary ribonuclease; A2 >P, di-adenylate containing 2’,3’ cyclic phosphate
(product of cA4 cleavage). (B) Free cA4 (600 mM, blue; 60 mM, red; 6 mM, green) concentration and (C), RNA cleavage in presence of 1 mM Crn1 and 1
mM Csx1. (D) and (E) show equivalent plots in the presence of 1 mM AcrIII-1. Insets where present show a magnified view of the start of each plot. (F) 3D
plot visualising concentration of RNA (1000 mM at start) cleaved by Csx1 in response to 60 mM cA4 made by Csm complex, 1 mM Crn1 and varying
amounts of AcrIII-1 across a range of doubling endpoints. (G) 3D plot visualising concentration of RNA (1000 mM at start) cleaved by Csx1 in response
to 60 mM cA4 made by Csm complex, and varying concentrations of Csx1, Crn1 and AcrIII-1 enzymes.
The online version of this article includes the following source data, source code and figure supplement(s) for figure 6:
Source data 1. Raw data from modelling.
Source data 2. Extracted data from modelling.
Source code 1. KinTek model code for kinetic modelling in Figure 6.
Figure supplement 1. Modelling of RNA cleavage by Csx1 stimulated by cA4 synthesised in response to varying target RNA concentrations.
Figure supplement 2. Modelling of the relationship between Csx1 RNA cleavage and deactivation by ring nucleases with varying cA4 concentrations.
Figure supplement 3. Modelling of the effect of varying AcrIII-1 concentration on RNA cleaved by Csx1 in response to cA4 generated by 600 mM target
RNA.
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RNA cleavage of Listeria seeligeri Cas13a resulted in cell dormancy, providing herd immunity to the
bacterial population (Meeske et al., 2019). Similarly, in ecological contexts, it is possible that differ-
ent multiplicities of viral infection illicit different outcomes from the type III CRISPR response that
benefit either the individual cell or the population.
Cellular and viral ring nucleases reset the system in fundamentally
different ways
Biochemical comparison of Crn1 and AcrIII-1 revealed that both enzymes bind cA4 with dissociation
constants around 40 nM, around 3-fold tighter than observed for Csx1. However, Crn1 is a much
slower enzyme. Kinetic modelling of the antiviral signalling pathway confirms that Crn1 is effective
only at low levels of viral gene expression, where it has the potential to neutralise the toxicity associ-
ated with cA4-activated ribonucleases to offer a route for cell recovery without abrogating immunity.
In contrast, the much faster reaction kinetics of the anti-CRISPR ring nuclease means it can rapidly
deactivate Csx1 and immunosuppress cells even under very high RNA target (and thus cA4) levels.
Our modelling suggests that the rapid turnover of cA4 by AcrIII-1 over a wide concentration
range greatly limits RNA cleavage by deactivating defence enzymes. Therefore, the deployment of
AcrIII-1 upon viral infection may not only promote viral propagation but also safeguard cellular integ-
rity until viral release by lysis. Recent studies have uncovered that sequentially infecting phage evade
CRISPR defences by exploiting the immunosuppression achieved by Acr enzymes from failed infec-
tions (Borges et al., 2018; Landsberger et al., 2018). Further, these immunosuppressed cells have
been shown to be susceptible to Acr-negative phage infections, highlighting the complex ecological
consequences of supressing CRISPR immunity (Chevallereau et al., 2020). In Sulfolobus Turreted
Icosahedral virus (STIV), the AcrIII-1 gene B116 is expressed early in the viral life cycle
(Ortmann et al., 2008). Therefore, AcrIII-1 accumulation in the cell, possibly from early expression
by unsuccessful viruses may, as our models demonstrate, favour the success of latter viral infections.
Type III CRISPR systems also conditionally tolerate prophage (Goldberg et al., 2014), and unsurpris-
ingly, AcrIII-1 is found in a number of prophages and integrative and conjugative elements. In these
cases, constitutively expressed AcrIII-1 may further immunocompromise cells, and sensitise them to
infection by phage otherwise eradicated by type III CRISPR defence. In the ongoing virus-host con-
flict, while increasing Csx1 concentration may allow better immunity when faced with AcrIII-1, upre-
gulating AcrIII-1 expression in cells will undoubtedly offer viruses an avenue for counter offence.
It should be noted that the type III CRISPR locus of S. solfataricus contains a number of CARF
domain proteins and their contribution to immunity has not yet been studied. In particular, the
CARF-family putative transcription factor Csa3 appears to be involved in transcriptional regulation of
CRISPR loci, including the adaptation and type I-A effector genes, when activated by cA4 (Liu et al.,
2015; Liu et al., 2017). These observations suggest that the cA4 signal may transcend type III
CRISPR defence in some cell types by activating multiple defence systems. However, by degrading
the second messenger, AcrIII-1 has the potential to neutralise all of these.
Cyclic nucleotides in prokaryotic defence systems
Cyclic nucleotide-based defence systems are emerging as powerful cellular sentinels against para-
sitic elements in prokaryotes. Mirroring the role of cyclic GMP-AMP synthase (cGAS) in eukaryotic
defence against viruses as part of the cGAS-STING pathway, bacterial cGAS enzymes have recently
been discovered that abort infection by activating phospholipases through cGAMP signaling
(Cohen et al., 2019). Termed the cyclic-oligonucleotide-based antiphage signaling system (CBASS),
a large number of additional cOA sensing effector proteins associated with CBASS loci remain
uncharacterised, highlighting great diversity in the cellular arsenal used for defence
(Burroughs et al., 2015; Cohen et al., 2019). Furthermore, diverse nucleotide cyclases have been
identified that generate a range of cyclic nucleotides including cUMP-AMP, c-di-UMP and cAAG,
which are also likely to function in novel antiviral signal transduction pathways (Whiteley et al.,
2019). Type III systems also generate cyclic tri-adenylate (cA3) and cyclic penta-adenylate (cA5) mole-
cules. Whereas no signalling role has yet been ascribed to cA5, cA3 has been demonstrated to acti-
vate a family of DNases termed NucC which abort infection by degrading the host genome prior to
completion of the phage replication cycle (Lau et al., 2020).
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The balance between immunity, abortive infection and successful pathogen replication is likely to
be governed by enzymes that synthesise and degrade these cyclic nucleotide second messengers.
Just as prokaryotes with type III CRISPR require a means to degrade cOA in appropriate circumstan-
ces, eukaryotic cells have enzymes that degrade cGAMP to regulate cGAS-STING mediated immu-
nity (Li et al., 2014). Likewise, while prokaryotic viruses utilise AcrIII-1 to rapidly degrade cA4,
eukaryotic poxviruses utilise Poxins to subvert host immunity by destroying cGAMP
(Eaglesham et al., 2019), and pathogenic Group B Streptococci degrade host c-di-AMP using the
CndP enzyme to circumvent innate immunity (Andrade et al., 2016). The rate of discovery of new
defence pathways and cyclic nucleotide signals is breath-taking. Analysis of the dynamic interplay
between enzymes that leads to fluctuations in the levels of these second messengers is therefore of
crucial importance if we are to achieve an understanding of these processes.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Gene
(Sulfolobus solfataricus)
Csm complex
(eight subunits)
PMID:24119402 virus expression
construct
Gene
(Sulfolobus solfataricus)
Csx1 PMID:29963983 UniProtKB -
Q97YD5
plasmid expression
construct
Gene
(Sulfolobus solfataricus)
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Cyclic oligoadenylate (cOA) synthesis and visualisation
Cyclic tetra-adenylate (cA4) made per RNA target (0.01, 0.1, 1, 10, 25 or 50 nM) was investigated in
a 20 ml reaction volume incubating A26 RNA target or A26 phosphorothioate RNA target (Table 1)
with 13.5 mg Sulfolobus solfataricus (Sso)Csm complex (~470 nM carrying A26 CRISPR RNA) in Csx1
buffer containing 20 mM MES pH 5.5, 100 mM K-glutamate, 1 mM DTT and 3 units SUPERase.In
Inhibitor supplemented with 1 mM ATP, 5 nM a-32P-ATP and 2 mM MgCl2 at 70˚C for 2 hr. All sam-
ples were deproteinised by phenol-chloroform extraction (Ambion) followed by chloroform (Sigma-
Aldrich) extraction prior to separating the cOA products by thin-layer chromatography (TLC). TLC
was carried out as previously described (Rouillon et al., 2019). In brief, 1 ml of radiolabelled cOA
product was spotted 1 cm from the bottom of a 20  20 cm silica gel TLC plate (Supelco Sigma-
Aldrich). The TLC plate was placed in a sealed glass chamber pre-warmed at 37˚C containing 0.5 cm
of a running buffer composed of 30% H2O, 70% ethanol and 0.2 M ammonium bicarbonate, pH 9.2.
After TLC the plate was air dried and sample migration visualised by phosphor imaging. For analysis,
Table 1. Oligonucleotides.
CRISPR RNA A26 is shown 3’ to 5’. Phosphorothioate linkages are indicated with an asterisk. Regions complementary to CRISPR RNA
A26 are italicized.
Crispr rna a26 3’-GCAACAATTCTTGCTGCAACAATCTTCAACCCATACCAGAAAGUUA
Name Sequence (5’ 3’)
Target RNA A26 AGGGUCGUUGUUAAGAACGACGUUGUUAGAAGUUGGGUAUGGUGGAGA
Phosphorothioate target RNA A26 AGGGUCGUUGUUAAGAACGACGUUGU*U*A*GAAGUUGGGU*A*U*GGUGGAGA
A1 substrate RNA AGGGUAUUAUUUGUUUGUUUCUUCUAAACUAUAAGCUAGUUCUGGAGA
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densiometric signals corresponding to cA4 was quantified as previously described (Rouillon et al.,
2019).
Generation of a-32P-ATP standard curves
cA4 synthesis was visualised by incorporation of 5 nM a-
32P-ATP added together with 0.5 mM ATP
at the start of the reaction. Therefore, to calculate the concentration of ATP used for cA4 synthesis,
a-32P-ATP standard curves were generated in duplicate, starting with 5 nM a-32P-ATP within a 20 ml
volume to represent the densiometric signal corresponding to the complete conversion of 0.5 mM
ATP into cOA. Serial two-fold dilutions of 5 nM a-32P-ATP and 0.5 mM ATP starting from a 20 ml vol-
ume were made and 1 ml of each dilution was spotted on a silica plate and phosphorimaged along-
side TLC separating cOA made with varying RNA target concentrations. After phosphorimaging, the
densiometric signals of the serial dilutions were quantified, averaged and plotted against ATP con-
centration starting from 0.5 mM and halving with each two-fold dilution. A line of best fit was then
drawn. The concentration of ATP used to synthesise cA4 was calculated by entering the densiometric
signal of the cA4 product into to equation of the line of best fit for the a-
32P-ATP standard curve.
The concentration of cA4 generated was derived by dividing the concentration of ATP incorporated
by four to account for polymerisation of four ATP molecules to generate one molecule of cA4.
Finally, the molecules of cA4 made per RNA was calculated by dividing the cA4 concentration gener-
ated by the concentration A26 RNA target used for cOA synthesis.
Calculation determining the concentration of cA4 made when one RNA target is detected within
a S. solfataricus cell of » 0.8 mm (0.6–1.0 mm) diameter.
Volume Vð Þ ¼
4
3
pr
3
and r¼
1
2
d
r¼
1
2
 0:8m
r¼ 0:4m
V ¼
4
3
pð0:4mÞ3
V ¼ 0:268m3
1m
3 ¼ 1fL
0:268m
3 ¼ 0:268 fL¼ 2:68 10 13mL
1 mole of RNA ¼ 6:022 1023 molecules of RNA
1 molecule of RNA ¼ 1 6:022 1023 ¼ 1:661 10 24 moles of RNA
As ~1000 molecules of cA4 is made per 1 molecule of RNA
1:661  10 24moles  1000 ¼ 1:661  10 21 moles of cA4
Concentration (M) = moles / Volume (L)
1:661  10 21 moles  2:68 10 16L¼ 6:20 10 6Mor6:20M cA4
Electrophoretic mobility shift assays to determine cA4 equilibrium
binding constants
~20 nM radioactively-labelled cA4 generated using the SsoCsm was incubated with increasing con-
centrations of Csx1 (0.01, 0.05, 0.10, 0.20, 0.40, 0.60, 0.80, 1,0, 2.0, 4.0, 8.0, 10.0, 20.0 mM protein
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dimer) in buffer containing 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM MgCl2 supplemented with
2 mM Ultrapure Bovine Serum Albumin (Invitrogen) for 10 min at 25˚C. A reaction volume equivalent
of 20% (v/v) glycerol was then added prior to loading the samples on a 15% polyacrylamide, 1 X TBE
gel. Electrophoresis was carried out at 28˚C and 250 V. Gels were phosphor imaged overnight at
 80˚C. For investigating RNA binding, 50 nM 5’-end radiolabelled and gel purified A1 RNA was
incubated with Csx1 variant H345N (0.01, 0.10, 1.0, 5.0, 10.0, 20.0 mM protein dimer) in the pres-
ence or absence of 20 mM cA4 for 15 min at 40˚C. To examine cA4 binding by Crn1,~10 nM radiola-
belled SsoCsm cA4 was incubated with Sso2081 (0.01, 0.05, 0.10, 0.20, 0.40, 0.60, 0.80, 1,0, 2.0, 4.0,
8.0, 10.0, 20.0 mM protein dimer) on ice for 15 min before gel electrophoresis as described above
but at 300V and at 4˚C. cA4 binding by AcrIII-1 was examined by incubating ~10 nM radiolabelled
SsoCsm cA4 with SIRV1 gp49 H47A (0.001, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.08, 0.10, 1.0, 10.0,
20.0 mM protein dimer) for 10 min at 25˚C before gel electrophoresis at 30˚C as described above.
For analysis densiometric signal corresponding to cA4 bound protein was quantified. The densiomet-
ric count corresponding to cA4 bound to 20 mM Csx1 dimer was used to represent 100% binding
and densiometric counts from other lanes were normalised to this value within each replicate. Error
of the 100% bound (20 mM Csx1 dimer) densiometric count was derived by calculating the area
adjusted count for each replicate and then the standard deviation of their mean, reporting the stan-
dard deviation as a fraction of the mean set as 100% bound. The data were fitted to a quadratic
equation with an adjust for nonspecific binding (Y = (ymax-ymin)*((x + [ligand] + Kd) - ((x+[ligand]
+Kd)^2–4*x*[ligand])^0.5)/(2*[ligand]) +a*x+b) using GraphPad Prism 8.
Multiple turnover kinetics of RNA cleavage by Csx1
Multiple turnover kinetic experiments were carried out by incubating Csx1 (0.125 mM dimer) with
radiolabelled (50 nM) and unlabelled RNA A1 to a final concentration of 1.25, 1.5, 2.0, 5.0, 10.0, or
20.0 mM RNA in Csx1 buffer at 70˚C. Control reactions with no protein and with protein and RNA in
the absence of cA4 were included. 10 ml reaction aliquots were quenched by adding to phenol-chlo-
roform and vortexing and the different time-points at which reactions were quenched for each RNA
concentration is indicated in data transparency. Deproteinised products were run on a 7 M urea,
20% acrylamide, 1 X TBE gel at 45˚C as previously described (Rouillon et al., 2019), and phosphor-
imaged overnight at  80˚C. Each experiment was carried out in triplicate. Fraction of RNA cut was
plotted against time and a linear regression was carried out on the linear portion of each plot to
determine the initial rate of RNA cleavage at each RNA concentration. To determine the parameters
kcat and KM, the average initial rate of RNA cleavage was plotted against RNA concentration and fit-
ted to the Michaelis-Menten equation using GraphPad Prism 8.
Modelling antiviral signalling and its control by ring nucleases
Modelling was carried out using the KinTek Explorer eight software package (Johnson, 2009), which
is available from (https://kintekcorp.com/software). Experiments were modelled and simulated using
kinetic and equilibrium paramters detemined experimentally as described in Figure 6A. The follow-
ing steps were inserted to generate the model:
target_Csm_ATP = target_Csm + cA4 (irreversible)
cA4 + Csx1 = cA4_Csx1
cA4_Csx1 + RNA = cA4_Csx1_RNA
cA4_Csx1_RNA = cA4_Csx1_cleavedRNA (irreversible)
cA4_Csx1_cleavedRNA = cA4_Csx1 + cleavedRNA
cA4 + Crn1 = cA4_Crn1
cA4_Crn1 = A2 + Crn1 (irreversible)
cA4 + Vrn = cA4_Vrn cA4_Vrn = A2 + Vrn (irreversible)
Simulations were carried out varying target_Csm_ATP concentration (6, 60 and 600 mM) while
Csx1, Crn1 (Sso2081) and AcrIII-1 concentrations were fixed at 1 mM dimer, or varied depending on
the simulation, with total substrate RNA in the cell fixed at 1000 mM.
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